BioCryst Pharmaceuticals
BCRX
#4880
Rank
โ‚ฌ1.69 B
Marketcap
6,58ย โ‚ฌ
Share price
-1.37%
Change (1 day)
9.58%
Change (1 year)

Earnings for BioCryst Pharmaceuticals (BCRX)

Earnings in 2026 (TTM): -โ‚ฌ0.31 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's current earnings are โ‚ฌ0.96 Billion. In 2025 the company made an earning of โ‚ฌ0.24 Billion, an increase over its 2024 earnings that were of -โ‚ฌ79.25 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioCryst Pharmaceuticals from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ0.31 Billion-226.36%
2025 โ‚ฌ0.24 B-407.51%
2024 -โ‚ฌ79.25 Million-61.56%
2023 -โ‚ฌ0.21 Billion-7.43%
2022 -โ‚ฌ0.23 Billion34.42%
2021 -โ‚ฌ0.17 Billion-0.55%
2020 -โ‚ฌ0.17 Billion67.88%
2019 -โ‚ฌ99.25 Million7.55%
2018 -โ‚ฌ92.29 Million53.92%
2017 -โ‚ฌ59.96 Million19.29%
2016 -โ‚ฌ50.26 Million28.19%
2015 -โ‚ฌ39.21 Million-4.8%
2014 -โ‚ฌ41.19 Million50.09%
2013 -โ‚ฌ27.45 Million-23.29%
2012 -โ‚ฌ35.78 Million-26.19%
2011 -โ‚ฌ48.47 Million54.78%
2010 -โ‚ฌ31.32 Million150.1%
2009 -โ‚ฌ12.53 Million-49.43%
2008 -โ‚ฌ24.76 Million14.07%
2007 -โ‚ฌ21.71 Million-49.31%
2006 -โ‚ฌ42.82 Million72.87%
2005 -โ‚ฌ24.77 Million22.08%
2004 -โ‚ฌ20.29 Million75.3%
2003 -โ‚ฌ11.58 Million-25.36%
2002 -โ‚ฌ15.51 Million225.05%
2001 -โ‚ฌ4.78 Million-56.6%
2000 -โ‚ฌ11 Million50.63%
1999 -โ‚ฌ7.3 Million38.05%
1998 -โ‚ฌ5.29 Million-52.46%
1997 -โ‚ฌ11.12 Million58.44%
1996 -โ‚ฌ7.02 Million-14.44%
1995 -โ‚ฌ8.21 Million28.57%
1994 -โ‚ฌ6.38 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
-โ‚ฌ2.31 Billion 614.06%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ6.52 B-2,116.87%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-โ‚ฌ0.12 Billion-63.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚ฌ27.95 M-108.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-โ‚ฌ0.21 Billion-37.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚ฌ0.3 Billion-8.15%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-โ‚ฌ7.5 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚ฌ20.29 Million-93.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-โ‚ฌ0.18 Billion-45.14%๐Ÿ‡บ๐Ÿ‡ธ USA